The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Subcutaneous Drug Delivery Devices Market Research Report 2024

Global Subcutaneous Drug Delivery Devices Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1548952

No of Pages : 78

Synopsis
A subcutaneous drug delivery device having a housing having an internal reservoir in communication with a drug delivery needle via a fluid path. An expandable chamber disposed adjacent to the reservoir forces drug from the reservoir to the needle when supplied with a gas.
The global Subcutaneous Drug Delivery Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Subcutaneous Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Drug Delivery Devices.
Report Scope
The Subcutaneous Drug Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Subcutaneous Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Drug Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Segment by Type
Prefilled Injectable
Filled Injectable
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Subcutaneous Drug Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Subcutaneous Drug Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Subcutaneous Drug Delivery Devices Market Overview
1.1 Product Overview and Scope of Subcutaneous Drug Delivery Devices
1.2 Subcutaneous Drug Delivery Devices Segment by Type
1.2.1 Global Subcutaneous Drug Delivery Devices Market Value Comparison by Type (2024-2030)
1.2.2 Prefilled Injectable
1.2.3 Filled Injectable
1.3 Subcutaneous Drug Delivery Devices Segment by Application
1.3.1 Global Subcutaneous Drug Delivery Devices Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Drug Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Drug Delivery Devices Revenue 2019-2030
1.4.2 Global Subcutaneous Drug Delivery Devices Sales 2019-2030
1.4.3 Global Subcutaneous Drug Delivery Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Subcutaneous Drug Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Subcutaneous Drug Delivery Devices Average Price by Manufacturers (2019-2024)
2.4 Global Subcutaneous Drug Delivery Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Drug Delivery Devices, Product Type & Application
2.7 Subcutaneous Drug Delivery Devices Market Competitive Situation and Trends
2.7.1 Subcutaneous Drug Delivery Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Subcutaneous Drug Delivery Devices Players Market Share by Revenue
2.7.3 Global Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Subcutaneous Drug Delivery Devices Retrospective Market Scenario by Region
3.1 Global Subcutaneous Drug Delivery Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Subcutaneous Drug Delivery Devices Global Subcutaneous Drug Delivery Devices Sales by Region: 2019-2030
3.2.1 Global Subcutaneous Drug Delivery Devices Sales by Region: 2019-2024
3.2.2 Global Subcutaneous Drug Delivery Devices Sales by Region: 2025-2030
3.3 Global Subcutaneous Drug Delivery Devices Global Subcutaneous Drug Delivery Devices Revenue by Region: 2019-2030
3.3.1 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2019-2024
3.3.2 Global Subcutaneous Drug Delivery Devices Revenue by Region: 2025-2030
3.4 North America Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.4.1 North America Subcutaneous Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Subcutaneous Drug Delivery Devices Sales by Country (2019-2030)
3.4.3 North America Subcutaneous Drug Delivery Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Subcutaneous Drug Delivery Devices Sales by Country (2019-2030)
3.5.3 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Subcutaneous Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Subcutaneous Drug Delivery Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Subcutaneous Drug Delivery Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Subcutaneous Drug Delivery Devices Sales by Country (2019-2030)
3.7.3 Latin America Subcutaneous Drug Delivery Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Drug Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Drug Delivery Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Subcutaneous Drug Delivery Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Subcutaneous Drug Delivery Devices Sales by Type (2019-2030)
4.1.1 Global Subcutaneous Drug Delivery Devices Sales by Type (2019-2024)
4.1.2 Global Subcutaneous Drug Delivery Devices Sales by Type (2025-2030)
4.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2019-2030)
4.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2019-2030)
4.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Type (2019-2024)
4.2.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2025-2030)
4.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2019-2030)
4.3 Global Subcutaneous Drug Delivery Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Subcutaneous Drug Delivery Devices Sales by Application (2019-2030)
5.1.1 Global Subcutaneous Drug Delivery Devices Sales by Application (2019-2024)
5.1.2 Global Subcutaneous Drug Delivery Devices Sales by Application (2025-2030)
5.1.3 Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2019-2030)
5.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2019-2030)
5.2.1 Global Subcutaneous Drug Delivery Devices Revenue by Application (2019-2024)
5.2.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2025-2030)
5.2.3 Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2019-2030)
5.3 Global Subcutaneous Drug Delivery Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Corporation Information
6.1.2 BD Description and Business Overview
6.1.3 BD Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BD Subcutaneous Drug Delivery Devices Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Insulet Corporation
6.2.1 Insulet Corporation Corporation Information
6.2.2 Insulet Corporation Description and Business Overview
6.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Product Portfolio
6.2.5 Insulet Corporation Recent Developments/Updates
6.3 Enable Injections
6.3.1 Enable Injections Corporation Information
6.3.2 Enable Injections Description and Business Overview
6.3.3 Enable Injections Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Enable Injections Subcutaneous Drug Delivery Devices Product Portfolio
6.3.5 Enable Injections Recent Developments/Updates
6.4 West Pharmaceutical Services, Inc
6.4.1 West Pharmaceutical Services, Inc Corporation Information
6.4.2 West Pharmaceutical Services, Inc Description and Business Overview
6.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product Portfolio
6.4.5 West Pharmaceutical Services, Inc Recent Developments/Updates
6.5 Ypsomed AG
6.5.1 Ypsomed AG Corporation Information
6.5.2 Ypsomed AG Description and Business Overview
6.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Product Portfolio
6.5.5 Ypsomed AG Recent Developments/Updates
6.6 Elcam Medical
6.6.1 Elcam Medical Corporation Information
6.6.2 Elcam Medical Description and Business Overview
6.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Product Portfolio
6.6.5 Elcam Medical Recent Developments/Updates
6.7 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Amgen Subcutaneous Drug Delivery Devices Product Portfolio
6.7.5 Amgen Recent Developments/Updates
6.8 Wilhelm Haselmeier
6.8.1 Wilhelm Haselmeier Corporation Information
6.8.2 Wilhelm Haselmeier Description and Business Overview
6.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product Portfolio
6.8.5 Wilhelm Haselmeier Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Drug Delivery Devices Industry Chain Analysis
7.2 Subcutaneous Drug Delivery Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Drug Delivery Devices Production Mode & Process
7.4 Subcutaneous Drug Delivery Devices Sales and Marketing
7.4.1 Subcutaneous Drug Delivery Devices Sales Channels
7.4.2 Subcutaneous Drug Delivery Devices Distributors
7.5 Subcutaneous Drug Delivery Devices Customers
8 Subcutaneous Drug Delivery Devices Market Dynamics
8.1 Subcutaneous Drug Delivery Devices Industry Trends
8.2 Subcutaneous Drug Delivery Devices Market Drivers
8.3 Subcutaneous Drug Delivery Devices Market Challenges
8.4 Subcutaneous Drug Delivery Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’